Mainstream Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.2K Buy
+100
New +$39.9K 0.02% 150
2025
Q1
– Sell
-182
Closed -$47.4K – 96
2024
Q4
$47.4K Buy
+182
New +$54K 0.03% 143

Other funds holding AMGN

Mainstream Capital Management's AMGN Position: Q3 2026 in Review

Mainstream Capital Management opened a new position in Amgen (AMGN) in Q3 2026: 100 shares worth $42.2K. The stake represents 0.02% of the portfolio and ranks #150 among its holdings. This is a return to the name: Mainstream Capital Management previously reported a position in AMGN as recently as Q4 2024.

Mainstream Capital Management first reported a position in AMGN in Q4 2024 and has held it in 2 quarters since. The position peaked at $47.4K in Q4 2024. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Mainstream Capital Management held 100 shares of Amgen worth $42.2K as of Q3 2026.
  • Amgen was a new Mainstream Capital Management position in Q3 2026.
  • Amgen made up 0.02% of Mainstream Capital Management's portfolio in Q3 2026, its #150 holding.
  • Mainstream Capital Management first reported a position in Amgen in Q4 2024 and has held it in 2 quarters since.
  • Mainstream Capital Management's Amgen position peaked at $47.4K in Q4 2024.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Mainstream Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.